# Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer

> **NCT00389610** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 56 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** GVAX pancreas vaccine

## Key facts

- **NCT ID:** NCT00389610
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-11
- **Primary completion:** 2021-10-11
- **Final completion:** 2022-12-10
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-10-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389610, "Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00389610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*